Literature DB >> 9262289

Cryopreservation: the practicalities of evaluation.

H W Jones1, H J Out, E H Hoomans, S G Driessen, H J Coelingh Bennink.   

Abstract

An attempt was made to integrate data from cryopreserved embryos with those from fresh embryos to obtain a realistic assessment of the role of cryopreservation in assisted reproductive treatment. Principles were applied to previously published data from a large prospective randomized multicentre study comprising recombinant and urinary follicle stimulating hormone in in-vitro fertilization.

Mesh：

Substances：

Year:  1997        PMID： 9262289     DOI： 10.1093/humrep/12.7.1522

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


  5 in total

1.  The influence of prefreeze growth rate and blastomere number on cryosurvival and subsequent implantation of human embryos.

Authors:  D H Edgar; H Jericho; H Bourne; J C McBain
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

2.  A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI.

Authors:  Eric H M Hoomans; Bernard B Mulder
Journal:  J Assist Reprod Genet       Date:  2002-10       Impact factor: 3.412

3.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

4.  A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.

Authors:  Seang Lin Tan; Timothy J Child; Anthony P Cheung; Margo R Fluker; Albert Yuzpe; Robert Casper; Peter Leung; Kenneth Cadesky; Victoria J Davis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

5.  Affordable ART for developing countries: a cost benefit comparison of low dose stimulation versus high dose GnRH antagonist protocol.

Authors:  M Noorashikin; F B Ong; M H Omar; M R Zainul-Rashid; A Z Murad; A Shamsir; M A Norsina; A Nurshaireen; N S M N Sharifah-Teh; A H Fazilah
Journal:  J Assist Reprod Genet       Date:  2008-07-25       Impact factor: 3.412
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.